Yuflyma

1 minute read

Business

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with…

bySarjatha Kp

July 18, 2022

The Latest

The Ministry Of Energy Signs the Final Concession Agreements to Build and Operate Eight Power Plants with A Total Capacity Of 5000 MW With A Foreign Consortium Led by UCC Holding

JBK Group Partners with Voltage Park and Matrice.ai For Vision AI Factory Deployments Across Qatar

Hikma confirms 2025 guidance and updates medium-term growth outlook

10X Health and REVIV Global Announce Strategic Partnership with M42 to Launch 10XREVIV in Abu Dhabi

Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region

The Ministry Of Energy Signs the Final Concession Agreements to Build and Operate Eight Power Plants with A Total Capacity Of 5000 MW With A Foreign Consortium Led by UCC Holding

JBK Group Partners with Voltage Park and Matrice.ai For Vision AI Factory Deployments Across Qatar

Hikma confirms 2025 guidance and updates medium-term growth outlook

10X Health and REVIV Global Announce Strategic Partnership with M42 to Launch 10XREVIV in Abu Dhabi

Phoenix Group Launches 30MW Hydropower Mining Operation in Ethiopia; H.C. Wainwright Reaffirms Buy Rating and AED 3.00 Price Target

First in Human Ischemic VT Ablation Successfully Performed in iCMR

H.E. Dr. Rumaih Al-Rumaih to Spotlight Saudi Mobility Leadership at CoMotion GLOBAL in Riyadh

Doha Debates Explores the Role of Ancient Wisdom in Today’s World